DJIA 18,034.93 208.63 1.17%
NASDAQ 4,994.60 62.79 1.27%
S&P 500 2,100.40 19.22 0.92%
market minute promo

Exelixis (NASDAQ: EXEL)



company name or ticker

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

The Zacks Analyst Blog Highlights: Rigel Pharmaceuticals, Exelixis and Atlas Resource Partners - Pre

The Zacks Analyst Blog Highlights: Rigel Pharmaceuticals, Exelixis and Atlas Resource Partners - Press Releases

Best Pure Play Investment in Cancer Drugs

Global cancer drug sales could soon soar past $100 billion, making this pure play in cancer drugs a stock you should seriously consider owning.

3 Momentum Picks Under $10 to Sail the Turbulent Market - Analyst Blog

Exelexis (EXEL) Is The 'Chart of the Day'

3 Biotech Stocks That May Disappear Before 2020

Our experts weigh in.

2 Speculative Biotechs That Could Be Well Worth the Risk

Celladon Corp. and Exelixis Inc. are two speculative biotech stocks that might be worth their substantial risks.

Exelixis' Cometriq Gets Fast Track Status in U.S. - Analyst Blog

Exelixis (EXEL) Stock Rises Today Following FDA Fast Track Designation

Health Care Sector Update for 04/09/2015: EXEL,NVGN,TRIV

See More Articles...